Jin Yang Pharmaceuticals Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jin Yang Pharmaceuticals Co Ltd with three other
companies in this sector in South Korea:
Aprogen Pharmaceuticals Inc
sales of 45.40 billion Korean Won [US$38.18 million]
of which 1%
Samsung Pharmaceutical Co Ltd
(46.48 billion Korean Won [US$39.09 million]
of which 92%
was Pharmaceuticals Segment), and
Ildong Holdings Co Ltd
(47.05 billion Korean Won [US$39.57 million]
of which 30%
Jin Yang Pharmaceuticals Co Ltd reported sales of 46.86 billion Korean Won (US$39.41 million)
December of 2018.
increase of 7.9%
versus 2017, when the company's sales were 43.45 billion Korean Won.